Active	Status	Sponsor type	Region	Phase	Filter
4 Active 5 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Yang, Yue
NCT05525637: Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder	Recruiting	3	1041	RoW	YZJ-1139 20mg, YZJ-1139 40mg, Placebo	Shanghai Haiyan Pharmaceutical Technology Co., Ltd.	Insomnia Disorder	12/24	12/24
LIBRETTO-432, NCT04819100 / 2020-005191-35: A Study of Selpercatinib After Surgery or Radiation in Participants With Non-Small Cell Lung Cancer (NSCLC)	Recruiting	3	170	Europe, Canada, Japan, US, RoW	Selpercatinib, LY3527723, LOXO-292, Placebo	Loxo Oncology, Inc., Eli Lilly and Company	Carcinoma, Non-Small-Cell Lung	05/27	08/32
Wu, Xiujuan
NCT05525637: Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder	Recruiting	3	1041	RoW	YZJ-1139 20mg, YZJ-1139 40mg, Placebo	Shanghai Haiyan Pharmaceutical Technology Co., Ltd.	Insomnia Disorder	12/24	12/24